Medical News

RSS

IDRI launches LEISH-F3 + GLA-SE Phase 1 trial for kala-azar

The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat diseases of poverty. The Phase 1 trial is taking place in Washington State, with a companion Phase 1 trial planned in India, an epicenter of the disease.

23 Feb 2012

Health Canada accepts Paladin's Silenor NDS for review

Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.

23 Feb 2012

Women with migraine more likely to develop depression

New research suggests women who have migraine or have had them in the past are at an increased risk for developing depression compared to women who have never had migraine.

23 Feb 2012

Depomed, Santarus reach agreement to resolve GLUMETZA patent litigation with Lupin

Santarus, Inc. and Depomed, Inc. today announced that they have entered into a settlement agreement with Lupin Ltd. and its subsidiary, Lupin Pharmaceuticals, Inc., to resolve pending patent litigation involving GLUMETZA 1000 mg and 500 mg.

23 Feb 2012

Chemists build light-controlled neural inhibitor

The notion of a pain switch is an alluring idea, but is it realistic? Well, chemists at LMU Munich, in collaboration with colleagues in Berkeley and Bordeaux, have now shown in laboratory experiments that it is possible to inhibit the activity of pain-sensitive neurons using an agent that acts as a photosensitive switch. For the LMU researchers, the method primarily represents a valuable tool for probing the neurobiology of pain.

23 Feb 2012

New microfluidic device can rapidly isolate target cells

Separating complex mixtures of cells, such as those found in a blood sample, can offer valuable information for diagnosing and treating disease. However, it may be necessary to search through billions of other cells to collect rare cells such as tumor cells, stem cells or fetal cells. "You're basically looking for a needle in a haystack," says Sukant Mittal, a graduate student in the Harvard-MIT Division of Health Sciences and Technology.

23 Feb 2012

Dyax fourth quarter total revenues decrease to $8.5 million

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2011.

22 Feb 2012

NCQA awards MHC Distinction to Health Net of California

Health Net of California, Inc., a subsidiary of Health Net, Inc., announced today that its HMO, POS, PPO, Healthy Families Program and Medicaid lines of business have been awarded the Multicultural Health Care (MHC) Distinction by the National Committee for Quality Assurance.

22 Feb 2012

China's SFDA approves Dynex DS2 ELISA analyzer

Dynex Technologies announced today it has received approval from China's State Food and Drug Administration (SFDA) to market the DS2 automated enzyme-linked immunosorbent assay (ELISA) analyzer in China.

From Thermo Fisher Scientific Inc. 22 Feb 2012

Causal link between TBI and increased susceptibility to PTSD

Mild traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are cardinal injuries associated with combat stress, and TBI increases the risk of PTSD development. The reasons for this correlation have been unknown, in part because physical traumas often occur in highly emotional situations.

22 Feb 2012

CardioNet fourth quarter revenue decreases 6.6% to $26.8 million

CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the fourth quarter and full year-ended December 31, 2011.

22 Feb 2012

Statins can reduce risk of depression

Researchers at Charité - Universitätsmedizin Berlin and the University of California San Francisco have studied the link between medication taken for cardiovascular disease and the development of depression. In their studies, scientists have determined that a particular class of medication, i.e. statins, can reduce the risk of developing depression.

22 Feb 2012

Osseon's new vertebral augmentation device receives European CE Mark approval

Osseon® Therapeutics, Inc. announced today that its newest product for vertebral augmentation treatment, the Osseoflex SB (steerable balloon), received CE Mark approval for commercial release in the European Union.

22 Feb 2012

Department of Veterans Affairs introduces Health Benefits Handbook

Veterans enrolled in the health care system of the Department of Veterans Affairs have begun to receive personalized booklets that explain their health care benefits and contain other useful information.

22 Feb 2012

People with celiac disease are at risk for osteoporosis

People with celiac disease are at risk for osteoporosis, according to physicians at Loyola University Health System (LUHS). A 2009 New England Journal of Medicine study supports this correlation. Researchers believe that people with celiac disease may develop osteoporosis because their body poorly absorbs calcium and vitamin D, which are necessary for bone health.

22 Feb 2012

Questcor fourth quarter net sales increase to $75.5 million

Questcor Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2011.

22 Feb 2012

Political cartoon: 'High Occupancy?'

Kaiser Health News provides a fresh take on health policy developments with "High Occupancy?" by Mike Peters.

22 Feb 2012

Making a medicinewise choice between brands

Following reports the first generic version of atorvastatin will be hitting pharmacy shelves this week, NPS is urging consumers to be medicinewise when making a choice between medicine brands.

22 Feb 2012

Gluten-free diet more of a fad than absolute necessity for many

Many people claim that gluten sensitivity is on the rise and consequently gluten-free products are more popular than ever. A study explores whether shunning gluten is really necessary and finds that in most cases it is not.

22 Feb 2012

Facial cosmetic surgeries indeed take years off: Study

Going for a cosmetic surgery of the face may truly lead to a younger look according to researchers from the University of Toronto. Overall, patients looked an average of about 9 years younger than their chronological age after extensive facial surgery, in the opinion of raters who compared before-and-after pictures.

22 Feb 2012